01 6FRESENIUS KABI USA
01 27828787
02 27857802
03 28162915
01 6Blank
01 6Y
01 22024-05-23
02 22025-10-18
03 22026-11-28
Patent Expiration Date : 2026-11-28
US Patent Number : 7857802
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-11-28
Patent Expiration Date : 2024-05-23
US Patent Number : 8162915
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-05-23
Patent Expiration Date : 2024-05-23
US Patent Number : 8162915
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-05-23
Patent Expiration Date : 2025-10-18
US Patent Number : 7828787
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-18
Patent Expiration Date : 2025-10-18
US Patent Number : 7828787
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-18
Patent Expiration Date : 2026-11-28
US Patent Number : 7857802
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 20533
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-11-28
